STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION
正在进行男性和女性避孕临床试验的管道产品的状态确定和优先级
基本信息
- 批准号:10025430
- 负责人:
- 金额:$ 129.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-24 至 2023-09-23
- 项目状态:已结题
- 来源:
- 关键词:ArchivesClinicalClinical TrialsClinical Trials NetworkConsultationsContraceptive AgentsContraceptive methodsDataData AnalysesData CollectionDevelopmentEvaluationFemale Contraceptive AgentsFutureGuidelinesMale Contraceptive AgentsManuscriptsMethodsMissionMonitorMonitoring Clinical TrialsNational Institute of Child Health and Human DevelopmentProgram DevelopmentProtocols documentationResearchServicesSiteWomanmenprogramsprotocol developmentsuccess
项目摘要
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for women and for men. The Contraceptive Clinical Trials Network (CCTN) was established to provide qualified sites to perform clinical trials of new products. HD serves as the coordinator of these clinical trials at sites that have been pre-qualified to conduct a variety of clinical trials. HD provides coordination of protocol development, clinical trial coordination and monitoring and data analysis for products that are currently in the Contraception Development Program developmental pipeline. The services needed for the activities described herein require a period of data evaluation including iterative data analysis, advisory consultation and regulatory review to reach a determination for the next stage of development or for archiving the information as required by regulatory guidelines.
SCOPE
To provide statistical and clinical coordination as well as monitoring of clinical trials, including services and support related to protocol completion, data collection, data analysis, manuscript development and regulatory summary document new products under development for contraception in women and men in order to determine status and prioritization for products in the CDP developmental pipeline.
尤尼斯·肯尼迪·施莱佛国家儿童健康和人类发展研究所(NICHD)的使命是为妇女和男子开发安全有效的避孕药具。建立了避孕药临床试验网络,为新产品的临床试验提供合格的地点。HD作为这些临床试验的协调者,在已经获得进行各种临床试验的资格预审的研究中心开展这些临床试验。HD为目前处于避孕开发计划开发管道中的产品提供方案开发、临床试验协调和监测及数据分析的协调。本文所述活动所需的服务需要一段时间的数据评估,包括迭代数据分析、咨询和监管审查,以确定下一阶段的开发或根据监管指南的要求存档信息。
范围
提供统计和临床协调以及临床试验监测,包括与方案完成、数据收集、数据分析、手稿开发和监管摘要文件相关的服务和支持,以确定CDP开发管道中产品的状态和优先顺序。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLINT DART其他文献
CLINT DART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLINT DART', 18)}}的其他基金
COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
用于男性避孕的雀酮睾酮凝胶临床试验的协调、监测、随访和评估
- 批准号:
10800827 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION
评价IM或SQ注射丁酸左炔诺孕酮(LB)用于女性避孕的PK和PD的研究
- 批准号:
10859762 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION
正在进行男性和女性避孕临床试验的管道产品的状态确定和优先级
- 批准号:
10934476 - 财政年份:2019
- 资助金额:
$ 129.56万 - 项目类别:
COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
用于男性避孕的雀酮睾酮凝胶临床试验的协调
- 批准号:
9538980 - 财政年份:2017
- 资助金额:
$ 129.56万 - 项目类别:
STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN
CCTN统计和临床协调中心
- 批准号:
10359020 - 财政年份:2017
- 资助金额:
$ 129.56万 - 项目类别:
COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
用于男性避孕的雀酮睾酮凝胶临床试验的协调
- 批准号:
10219874 - 财政年份:2017
- 资助金额:
$ 129.56万 - 项目类别:
CCTN - COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
CCTN - 男性避孕用雀酮睾酮凝胶临床试验的协调
- 批准号:
10788176 - 财政年份:2017
- 资助金额:
$ 129.56万 - 项目类别:
COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
用于男性避孕的雀酮睾酮凝胶临床试验的协调
- 批准号:
10329803 - 财政年份:2017
- 资助金额:
$ 129.56万 - 项目类别:
CCTN - COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
CCTN - 男性避孕用雀酮睾酮凝胶临床试验的协调
- 批准号:
10551152 - 财政年份:2017
- 资助金额:
$ 129.56万 - 项目类别:
STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN
CCTN统计和临床协调中心
- 批准号:
9538984 - 财政年份:2017
- 资助金额:
$ 129.56万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 129.56万 - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
Studentship
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 129.56万 - 项目类别: